A new linear glyceryl acid derived heptapeptide (1), together with known isocoumarin antibiotic, Y-05460M-A (2), were isolated from the culture of the deep sea sediment strain Sl 79 classified as "Paenibacillus profundus" sp. nov. Their structures were determined by 1D-and 2D-NMR techniques and ESI-MS/MS experiments. HPLC analysis of the Marfey derivatives in comparison to their analogs of authentic amino acids revealed that all amino acids in peptide 1, with an exception of Val, have the D-configuration. The compound 1 showed inhibitory activity against Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis, Enterococcus faecium as well as cytotoxic and moderate colony growth inhibitory activity against SK-MEL-28 cell line.
Marine bacteria have been proven to be potential producers of bioactive compounds with unique structural characteristics. During screening of deep sediment associated microorganisms for their antimicrobial activity we found and identified strain Sl 79 belonging to the genus Paenibacillus showing inhibitory activity against Gram-positive and Gram-negative indicator bacteria [1] . It has been reported Paenibacillus strains, isolated from a variety of ecological niches [2a] can produce a wide range of antibiotics active against different pathogens [2b] . Paenibacillus polymyxa, the type species of the genus, has long been known for its ability to produce two types of peptide antibiotics. One group is active against bacteria known as the polymyxins, polypeptins, gavaserin, saltavalin, and jolipeptin [3a-f] , and the other group is made up of the peptide antibiotics resistant against fungi, Gram-positive bacteria and actinomycetes. The latter group of peptide antibiotics includes a series of LI-F antibiotics, gatavalin, and fusaricidins [4a-e] . Our continuing search for antimicrobial metabolites from strain Sl 79 led to the isolation of two active compounds 1 and 2. Here, we describe the isolation and structural elucidation of new linear peptide (1) from this strain (Figure 1 ).
Peptide was obtained as colorless amorphous solid and was negative to the ninhydrin test, suggesting a blocked N-terminus. The ESI mass spectrum of isolated compound displayed a pseudomolecular ion peak at m/z 822.5 [M + Na] + . The molecular formula of the compound was determined to be C 38 H 69 N 7 O 11 by HRESI-MS ion peak [M-H]at m/z 798.5005, with 8 degrees of unsaturation and was fully supported by NMR spectral data ( Table  1) . The 1 H NMR spectrum displayed characteristics of a typical peptide, illustrating seven amide NH signals (δ H 8.07, 8.03, 7.99, 7.73, 7.72, 7.71, 7.63) and seven α-protons of amino acids (δ H 4.33, 4.31, 4.28, 4.24, 4.23, 4.15, 4.14) . In the 13 C NMR spectrum eight ester/amide-type carbonyls (δ C 170. 5, 171.5, 171.6, 171.8, 171.9, 172.0, 172.3, 173.7) , seven α-methine carbons (δ C 47.4, 48.3, 50.3, 50.9, 51.0, 51.3, and 57.7) , one primary oxygenated carbon (δ C 64.0) and one secondary oxygenated carbon (δ C 72.7) were observed. Examination of 1 H and 13 C NMR spectra of 1 indicated that it was a peptide containing all aliphatic amino acids. In agreement with the possible occurrence of amide functionalities, the IR spectrum showed bands at 3400-3500, 2855-2956, 1602 and 1238 cm -1 . Analysis of the 2D NMR spectra, including COSY, HSQC, NOESY, TOCSY, HSQC-TOCSY and HMBC (Table 1) , allowed for the complete spectroscopic assignment of three common amino acids: one unit of valine (Val), two alanine (Ala), four leucine (Leu) and one glyceric acid (Ga) residue. These 1 H and 13 C NMR assignments agree well with the literature data for amino acid and glyceric acid residues in peptide. Since eight carbonyl carbons accounted for eight of the unsaturations, the peptide was concluded to be linear. The amino acid sequence of 1 was determined by deductions from HMBC and NOESY experiments ( Table 1 ). HMBC correlations between the amide proton in amino acid residue n and the carbonyl carbon of adjacent residue n -1 indicated the sequence of peptide 1. The HMBC correlations from Ala 7 -NH (δ 8.07) and Leu 6 (δ 4.33) to Leu 6 -CO (δ 171.5), from Leu 6 -NH (δ 7.99) and Val 5 (δ 4.14) to Val 5 -CO (δ 170.5), from Val 5 -NH (δ 7.63) and Leu 4 (δ 4.31) to Leu 4 -CO (δ171.8), from Leu 4 -NH (δ 7.72) and Leu 3 (δ 4.24) to Leu 3 -CO (δ 171.6), from Leu 3 -NH (δ 7.73) and Ala 2 (δ 4.23) to Ala 2 -CO (δ 171.9), from Ala 2 -NH (δ 8.03) and Leu 1 (δ 4.28) to Leu 1 -CO (δ 172.0), from NPC Natural Product Communications 2013 Vol. 8 No. 3 381 -384 indicating the cleavage of amide bonds between Ala 7 /Leu 6 , Leu 6 /Val 5 , Val 5 /Leu 4 , Leu 4 /Leu 3 , Leu 3 /Ala 2 , and Ala 2 /Leu 1 . In addition to the b n-m + OH fragmentation series, N-terminal (+Na) fragment ion peaks of the a-type at m/z 705 (a 6 ), 592 (a 5 ), 493 (a 4 ), 380 (a 3 ), 267 (a 2 ) and 196 (a 1 ) were observed and indicated cleavage of α-CH-C=O bonds. The ESI-MS/MS of [M-H]at m/z 798 produced series C-terminus fragment ions of the y-type at m/z 710 (y 7 ), 597 (y 6 ), 526 (y 5 ), 413 (y 4 ), 300 (y 3 ), 201 (y 2 ) and 88 (y 1 ), which indicated cleavage of amide bonds between Ga/Leu 1 , Leu 1 /Ala 2 , Ala 2 /Leu 3 , Leu 3 /Leu 4 , Leu 4 /Val 5 , Val 5 /Leu 6 and Leu 6 /Ala 7 and supported the C-terminal sequence of peptide 1 (Figure 1) . The absolute configurations of the constituting amino acids in peptide were determined by acid hydrolysis followed by chiral derivatization with Marfey's reagent [4g] . HPLC analysis of the Marfey derivatives in comparison to their analogs of authentic amino acids revealed that all amino acids, with an exception of Val, have the D-configuration. The absolute configuration of the glyceric acid residue in 1 was not determined. The isolated peptide (1) exhibited inhibitory activity against S. aureus, S. epidermidis, B. subtilis and E. faecium and was inactive towards Xanthomonas sp. pv. badrii, E. coli, C. albicans and F. oxysporum (Table 2) . (a) Antimicrobial activity was assayed at a concentration of 1 mg/mL of each compound. The compound 1 showed potent cytotoxic activity against SK-MEL-28 cell line, which was comparable with activity of doxorubicin, used as a reference substance ( the long-range H, C-couplings, showed the compound to have a carbon skeleton of isocoumarin. Isocoumarins have been reported to exhibit antibacterial [5, 6] , cytotoxic [7a,b] and antiulcer [7c,8a] activities and many of them are produced by strains of the genus Bacillus. The 1 H and 13 C NMR spectra of 2 were similar to that of Y-05460M-A from Bacillus sp.
[8b]. The compound 2 showed antimicrobial activity against Gram-positive and Gram-negative indicatory microorganisms (Table 2) . Based on phenotypic characterization and phylogenetic analysis strain Sl 79 was proposed to be classified as "Paenibacillus profundus" sp. nov. [1] . Strain Sl 79 formed two stable colony morphotypes, white rough wrinkled (Rform) and dark yellow glistening (S-form). The active compounds were obtained after growth of strain Sl 79 (R-form) on agar medium, containing, Bacto peptone (1%), casein hydrolyzate (0.5%), yeast extract (0.5%), glucose (0.1%), K 2 HPO 4 (0.02%), MgSO 4 (0.005%), 500 mL seawater, 500 mL distilled water, for 5 d at 28°C.
Extraction and Isolation:
The agar plates obtained were extracted three times with 2000 mL of EtOH and then the solvent was removed under reduced pressure at 40°C to water. The aqueous residue was suspended in distilled water and partitioned with nhexane, ethyl acetate (EtOAc), and n-butanol. The n-hexane and EtOAc layers were dried over anhydrous Na 2 SO 4 , and the n-butanol layer was filtered (No.1 filter, Whatman) and all fractions were then evaporated to syrup. The active crude EtOAc extract was subjected to silica gel column chromatography and eluted initially with CHCl 3 /CH 3 OH (100:0-6:1, to give three active fractions. Active fractions eluted with CHCl 3 /CH 3 OH 96:4-8:2 were combined and concentrated to yield an active crude subfraction (57 mg), which was applied to Sephadex LH-20 and eluted with CH 3 OH to give two active subfractions (16 and 17 mg). The subfraction (16 mg) showed positive color reactions with ninhydrin (-NH 2 ) and FeCl 3 (phenolic OH) reagents. These active subfractions (16 and 17 mg) were further subjected to reversed-phase HPLC chromatography on YMC-Pack-ODS-A column (250 x 4.6 mm I.D, 5 μm, 12 nm) and gave active components 2 (t R 28.9 min, 10.0 mg), and 1 (t R 36.1 min, 4.0 mg), respectively. The system was operated at a flow rate of 0.8 mL/min with solvents A/B, detection by UV absorption at 226 nm. The mobile phase was a mixture of acetonitrile (A) : H 2 O/TFA (0.02%) (B). The gradient (A:B) was maintained at 10% in the first 10 min, then from 10 to 50% in 25 min, and maintained at 50% 7 min.
Marfey Analysis of Peptide:
A 100 µg sample of 1 was hydrolyzed at 110°C for 24 h with 200 µL of 6N HCl. This solution was evaporated to dryness, and the residue was dissolved in 50 µL water. To this amino acid solution were added 20 µL of 1M sodium bicarbonate and then 100 µL of 1% Na-(2,4-dinitro-5-fluorophenyl)-L-alaninamide (FDAA) in acetone. The solution was vortexed and incubated at 37°C for 60 min. Afterward, the reaction was quenched by the addition of 20 µL of 1N HCl, the reaction mixture was diluted with 810 µL of acetonitrile, and 5 µL of this solution was analyzed by HPLC on a YMC-Pack-ODS-A column (4.6 x 250 mm, S-5 µm, 12nm), heated at 40°C. For the HPLC gradient elution, mobile phase A was prepared from 0.01 M aqueous trifluoroacetic acid, which was adjusted to pH 3 by the addition of ammonium hydroxide, and the mobile phase B was acetonitrile. Linear gradients started with 25% mobile phase B and finished with 55% mobile phase B in 35 min. The system was allowed to equilibrate for 10 min at 25% mobile phase B prior to the next analysis. The flow rate was maintained as 1 mL/min with the UV detection at 340 nm. In the hydrolysate of 1 the retention times of the Ala FDAA, Val FDAA and Leu FDAA were 13.6, 18.6 and 30.2 min, respectively, which correspond to D-Ala, L-Val and D-Leu FDAA derivatives. [9] .
Cell Culture: The human cancer cell line SK-MEL-28 (melanoma) was cultured at 37°C and 5% CO 2 in DMEM medium (Biolot, Saint Petersburg, Russian Federation) containing 10% FBS, 2 mM Lglutamine (Dia-M, Moscow, Russian Federation) and 1% penicillin/streptomycin (Invitrogen, Paisley, UK). The cell line was purchased from the American Type Culture Collection, ATCC. Information regarding the genetic background of the cell line is available online at the ATCC website.
Cytotoxicity Assay (MTS-test):
The effect of the compounds on the cells viability was evaluated using the MTS test, using reduction of MTS into its formazan product [10] . Briefly, SK-MEL-28 cells were cultured for 12 h in 96-well plates (6 × 10 3 per well) in 100 μL/well of DMEM medium. The medium was then replaced with fresh medium containing substance at various concentrations in a total volume of 100 μL/well and the cells were incubated for 24, 48, or 72 h. Subsequently 20 μL of Cell Titer 96 Aqueous One Solution Reagent was added into each well, and MTS reduction was measured 2 h later spectrophotometrically at 492 and 690 nm as background using Quant equipment (Bio-Tek Instruments, Winooski, VT, USA). Results are represented as IC 50 of the substances against corresponding cells.
Colony Growth Assay:
The ability of the substance to inhibit the growth of cell colonies of the human cancer cell line SK-MEL-28 in soft agar was determined as described before [11] . Briefly, the assay was carried out in 6-well tissue culture plates. Human SK-MEL-28 cancer cells (8 × 10 3 cells/mL) were treated with various concentrations of the substance in 1 mL of 0.33% basal medium Eagle (BME)-agar containing 10% FBS over 3 mL of 0.5% BMEagar containing 10% FBS and various concentrations of the investigated substance. The cultures were maintained in a 37°C, 5% CO 2 incubator for a time period of 1 week, after which cell colonies were scored using an Olympus CKX31 inverted research microscope (Olympus, Center Valley, PA, USA).
Abbreviations: IC 50 : inhibition concentration 50%; INCC 50 : inhibition of number of colonies formed in soft agar concentration 50%.
